James Mond
2015
In 2015, James Mond earned a total compensation of $736.4K as Chief Scientific Officer and Chief Medical Officer at ADMA Biologics, a 21% increase compared to previous year.
Compensation breakdown
| Bonus | $122,500 |
|---|---|
| Option Awards | $258,842 |
| Salary | $347,115 |
| Other | $7,950 |
| Total | $736,407 |
Mond received $347.1K in salary, accounting for 47% of the total pay in 2015.
Mond also received $122.5K in bonus, $258.8K in option awards and $8K in other compensation.
Rankings
In 2015, James Mond's compensation ranked 9,306th out of 13,638 executives tracked by ExecPay. In other words, Mond earned more than 31.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,306 out of 13,638 | 32nd |
Division Manufacturing | 3,548 out of 5,187 | 32nd |
Major group Chemicals And Allied Products | 1,297 out of 1,857 | 30th |
Industry group Drugs | 1,057 out of 1,531 | 31st |
Industry Biological Products, Except Diagnostic Substances | 187 out of 260 | 28th |
Source: SEC filing on April 29, 2016.
Mond's colleagues
We found two more compensation records of executives who worked with James Mond at ADMA Biologics in 2015.
News
ADMA Biologics CEO Adam Grossman's 2021 pay jumps 122% to $4.4M
April 28, 2022
ADMA Biologics CEO Adam Grossman's 2020 pay rises 15% to $2M
April 7, 2021
ADMA Biologics CEO Adam Grossman's 2019 pay rises 10% to $1.7M
April 29, 2020
ADMA Biologics CEO Adam Grossman's 2018 pay falls 42% to $1.6M
April 24, 2019